Ultrasound‐Enabled Sonogenetics: Pioneering Advances in Cancer Theranostics DOI
Beibei Zhang,

Lianfeng Mo,

Rong Huang

и другие.

Advanced Functional Materials, Год журнала: 2024, Номер unknown

Опубликована: Дек. 10, 2024

Abstract The diagnosis and treatment of cancer face significant challenges. Thus, precise controllable methods for effective tumor management are required. Sonogenetics which combines ultrasound technology with genetic engineering provides a promising solution. This approach utilizes the non‐invasive nature deep tissue penetration capabilities to enable diagnostics targeted therapies cancer. review explores roles sonogenetics‐mediated in theranostics. fundamental properties mechanisms underlying sonogenetics first introduced. Then, this work summarizes representative applications therapy, including cell‐based therapies, bacteria‐based eradication cells. Additionally, diagnosis, focusing on engineered gas vesicles (GVs) situ generation GVs diagnostic purposes presented. Finally, challenges clinical translation potential well discussed.

Язык: Английский

Self-Cascaded Pyroptosis-STING Initiators for Catalytic Metalloimmunotherapy DOI
Qiao Yu,

Shumin Sun,

Nailin Yang

и другие.

Journal of the American Chemical Society, Год журнала: 2025, Номер unknown

Опубликована: Янв. 17, 2025

Gasdermin (GSDM)-mediated pyroptosis involves the induction of mitochondrial damage and subsequent release DNA (mtDNA), which is anticipated to activate cGAS-STING pathway, thereby augmenting antitumor immune response. However, challenges lie in effectively triggering cancer cells subsequently enhancing activation with specificity. Herein, we developed intelligent self-cascaded pyroptosis-STING initiators cobalt fluoride (CoF2) nanocatalysts for catalytic metalloimmunotherapy. CoF2 a semiconductor structure enzyme-like activity generated substantial amount reactive oxygen species (ROS) under stimulation by endogenous H2O2 exogenous ultrasound. Importantly, discovered that Co-based nanomaterials themselves induce cells. Therefore, initially acted as inducers, caspase-1/GSDMD-dependent via Co2+ ROS, leading mtDNA release. Subsequently, were further utilized STING agonists specifically capable detecting pathway. These cascade events triggered robust response, modulating immunosuppressive tumor microenvironment into an immune-supportive state, providing favorable support therapy. This innovative strategy not only significantly impeded growth primary but also elicited response augment efficacy checkpoint inhibitors preventing distant progression. Overall, this study proposed self-cascade activating amplifying pathway specificity mediated pyroptosis, representing valuable avenue future

Язык: Английский

Процитировано

2

Modulating the Electronic Structure of MnNi2S3 Nanoelectrodes to Activate Pyroptosis for Electrocatalytic Hydrogen‐Immunotherapy DOI
Jingrui Li, Gang Wang,

Zhaoyu Wen

и другие.

Advanced Materials, Год журнала: 2024, Номер unknown

Опубликована: Окт. 14, 2024

Abstract Hydrogen (H 2 ) therapy has demonstrated antitumor effect, but the therapeutic efficacy is restricted by low solubility and nontarget delivery of H . Electrolysis O electrocatalysts sustainably releases enormous amounts inspires precise for tumor therapy. Herein, manganese‐doped Ni S 3 nanoelectrodes (MnNi NEs) are designed electrocatalytic activation immunity to effectively potentiate ‐immunotherapy. atoms featuring empty 3d orbitals reduce initial energy barrier hydrogen evolution reaction (HER) promoting adsorption O. Moreover, Mn with different electronegativity modulate electronic structure facilitate desorption generated , thus enhancing HER activity MnNi NEs. Based on high activity, controllable (EHT) achieved in a voltage‐dependent manner. Mechanistically, NE‐mediated EHT induces mitochondrial dysfunction oxidative stress, which subsequently activates pyroptosis through typical ROS/caspase‐1/GSDMD signaling pathway. Furthermore, enhances infiltration CD8 + T lymphocytes into tumors reverses immunosuppressive microenvironment. This work demonstrates an electrocatalyst synergistic gas‐immunotherapy, may spark electrocatalyst‐based strategies.

Язык: Английский

Процитировано

4

A Highly Potent Os@Au‐TPA Coordination Structure‐Based Sonosensitizer for Tumor Sono‐Immunotherapies DOI

Pengfei Xie,

Xiao Rong,

Xuelian Qin

и другие.

Advanced Functional Materials, Год журнала: 2024, Номер 35(2)

Опубликована: Ноя. 18, 2024

Abstract Ultrasound (US) becomes an appealing modality for stimulating or amplifying immune responses during cancer therapy, which is also termed sono‐immunotherapy. However, the clinical prospect has not been fully realized due to scarcity of efficient sonosensitizers. Herein, first time a novel Os‐doped Au‐tri(pyridin‐4‐yl) amine coordination structure (Os@Au‐TPA)‐based sonosensitizer originally designed and synthesized sono‐immunotherapy breast‐metastasized tumors. Impressively, Os@Au‐TPA shows much higher US‐mediated 1 O 2 ‐producing activity than Au‐TPA as well other traditional sonosensitizers, example, ≈41.6 folds ce6, 19.5 times Protoporphyrin IX (PpIX), 12.0 Indocyanine Green (ICG), 11.1 Iron phthalocyanine (Pc(Fe)). The can only generate abundant ROS upon US irradiation implement sonodynamic therapy (SDT), cell apoptosis further immunogenic death, but alleviate hypoxia promote polarization M2 M1 macrophages enhance tumor immunogenicity. As result, when combined with PD‐L1 antibody, it remodels immunosuppressive microenvironment, achieves concurrent sonodynamic‐triggered activation, eradicates both original distant‐metastasized tumors efficiently. This work provides new strategy construct potent sonosensitizers from pyridine‐metal structures proves that high performance are crucial in boosting

Язык: Английский

Процитировано

2

NaCe0.7FX:Gd0.1,Tb0.2 nanoscintillator as a new sonosensitizer for potentiating cancer sonodynamic-immune therapy DOI
Luyao Liu, Yuqi Yang, Yan Wang

и другие.

Chemical Engineering Journal, Год журнала: 2024, Номер 497, С. 154566 - 154566

Опубликована: Авг. 5, 2024

Язык: Английский

Процитировано

1

Antimony Component Schottky Nanoheterojunctions as Ultrasound‐Heightened Pyroptosis Initiators for Sonocatalytic Immunotherapy DOI

Jihu Nie,

Nailin Yang,

Shumin Sun

и другие.

Angewandte Chemie, Год журнала: 2024, Номер unknown

Опубликована: Сен. 21, 2024

Abstract Pyroptosis, an inflammatory modality of programmed cell death associated with the immune response, can be initiated by bioactive ions and reactive oxygen species (ROS). However, ion‐induced pyroptosis lacks specificity, further exploration other that induce in cancer cells is needed. Sonocatalytic therapy (SCT) holds promise due to its exceptional penetration depth; however, rapid recombination electron‐hole (e − ‐h + ) pairs complex tumor microenvironment (TME) impede broader application. Herein, we discovered antimony (Sb)‐based nanomaterials induced cells. Therefore, Schottky heterojunctions containing Sb component (Sb 2 Se 3 @Pt) were effectively designed constructed via situ growth platinum (Pt) nanoparticles (NPs) on semiconductor narrow band gaps, which utilized as US‐heightened initiators highly effective boost SCT‐immunotherapy. Under US irradiation, excited electrons transferred from nanorods (NRs) co‐catalyst Pt junctions, bending prevented electron backflow achieved efficient ROS generation. Moreover, pores oxidized depleted overexpressed GSH TME, potentially amplifying The biological effects @Pt nanoheterojunction itself combined sonocatalytic amplification oxidative stress significantly Caspase‐1/GSDMD‐dependent SCT treatment not only restrained proliferation but also potent memory responses suppressed recurrence. Furthermore, integration this innovative strategy checkpoint blockade (ICB) elicited a systemic augmenting therapeutic impeding abscopal tumors. Overall, study provides opportunities explore pyroptosis‐mediated

Язык: Английский

Процитировано

1

Injectable hydrogel assisted formation of hydroxyl radical generating bioreactor enables photothermally enhanced chemodynamic and immunotherapy DOI
Jun Zheng, Tingting Shang, Xiaojing Leng

и другие.

Chemical Engineering Journal, Год журнала: 2024, Номер 500, С. 157141 - 157141

Опубликована: Окт. 28, 2024

Язык: Английский

Процитировано

0

An Oral Nanovaccine Secreted by Genetically Engineered and Ultrasound‐Responsive Bacteria for Colon Cancer Immunotherapy DOI
Jiexin Li, Ruiqi Yang, Yihang Yuan

и другие.

Advanced Functional Materials, Год журнала: 2024, Номер unknown

Опубликована: Дек. 4, 2024

Abstract Colorectal cancers represent a major global morbidity and mortality burden, neccessitating improved treatment paradigms. In this work, an ingestible, genetically engineered Escherichia coli ( E. ) 1917 termed “ (AH1‐CDA‐Co1)” is designed that upon ultrasound exposure secretes bacterial outer membrane vesicles (OMV) incorporating the AH1 tumor rejection epitope, enzyme producing stimulator of interferon genes (STING) agonist CDA, microfold cell‐targeting peptide Co1. For oral administration, polydopamine system (iPDA) coating on bacteria exploited to resist acidic condition in stomach, increase survival, prolong intestinal transit time. Upon harmless exposure, sustained secretion OMV vaccines triggered efficiently cross epithelium. Both cyclic GMP–AMP synthase (cGAS)‐STING TLR4 innate immune signaling pathways are activated, triggering long‐term antigen‐specific responses overcome immunosuppressive microenvironment. subcutaneous orthotopic murine colorectal models, (AH1‐CDA‐Co1)@iPDA inhibits growth prolongs survival without recurrence. also recurrence postoperative colonrectal model lymph node metastases. Taken together, demonstrates potent vaccine for colon cancer immunotherapy.

Язык: Английский

Процитировано

0

Ultrasound‐Enabled Sonogenetics: Pioneering Advances in Cancer Theranostics DOI
Beibei Zhang,

Lianfeng Mo,

Rong Huang

и другие.

Advanced Functional Materials, Год журнала: 2024, Номер unknown

Опубликована: Дек. 10, 2024

Abstract The diagnosis and treatment of cancer face significant challenges. Thus, precise controllable methods for effective tumor management are required. Sonogenetics which combines ultrasound technology with genetic engineering provides a promising solution. This approach utilizes the non‐invasive nature deep tissue penetration capabilities to enable diagnostics targeted therapies cancer. review explores roles sonogenetics‐mediated in theranostics. fundamental properties mechanisms underlying sonogenetics first introduced. Then, this work summarizes representative applications therapy, including cell‐based therapies, bacteria‐based eradication cells. Additionally, diagnosis, focusing on engineered gas vesicles (GVs) situ generation GVs diagnostic purposes presented. Finally, challenges clinical translation potential well discussed.

Язык: Английский

Процитировано

0